| Client Eligibility, Special Needs Dental Service (SNDS)
|
SESLHDPD/159 |
|
| COVID-19 Precinct/ Ward Stepdown and Decontamination Procedure
|
SESLHDPR/722 |
|
| Dabigatran
|
SESLHDPR/589 |
|
| Danaparoid - Safe Use of
|
SESLHDPR/600 |
|
| Death - Management of Sudden Unexpected Death in Infancy
|
SESLHDPR/634 |
|
| Death Screening and Review
|
SESLHDGL/071 |
|
| Decommissioning a Workplace
|
SESLHDPR/420 |
|
| Delegations of Authority Manual
|
SESLHDHB/027 |
|
| Delirium - Prevention, Assessment and Management of Delirium in Older People
|
SESLHDPR/345 |
|
| Diabetes - Management of Pre-Gestational Diabetes in Pregnancy Policy
|
SESLHDPD/283 |
|
| Diabetes – Gestational Diabetes Mellitus (GDM) Screening and Management Policy
|
SESLHDPD/282 |
|
| Dictated and Transcribed Letters (Outsourced)
|
SESLHDPR/742 |
|
| Diet Ordering in eMR
|
SESLHDPR/424 |
|
| Digital Asset Management Policy
|
SESLHDPD/322 |
|
| Dinoprostone
|
SESLHDPR/568 |
|
| Diphtheria, Tetanus and Pertussis vaccination for Ante/Postnatal Women
|
SESLHDPD/279 |
|
| Documentation in the Health Care Record
|
SESLHDPR/336 |
|
| Domperidone for treatment of low breastmilk supply
|
SESLHDPD/287 |
|
| Drug and Alcohol - Management of missed consecutive doses of Opioid Agonist Treatment
|
SESLHDPR/411 |
|
| Management of Deteriorating PAEDIATRIC Inpatient
|
SESLHDPR/284 |
|
| Management of the Deteriorating ADULT inpatient (excluding maternity)
|
SESLHDPR/697 |
|
| Management of the deteriorating MATERNITY woman
|
SESLHDPR/705 |
|
| Management of the Deteriorating NEONATAL Inpatient
|
SESLHDPR/340 |
|
| Neonatal Services Demand Management and Escalation Policy
|
SESLHDPD/304 |
|
| Notification of Death of Non-inpatients from an External Source
|
SESLHDPR/216 |
|
| Pain Management - Implantable Intrathecal Drug Delivery System
|
SESLHDPR/294 |
|
| SESLHD Post Anaesthetic Care Unit (PACU) Discharge Guidelines, Post-Operative Adult and Maternity Patients
|
SESLHDGL/049 |
|
| Staphylococcus aureus (MSSA and MRSA) decolonisation
|
SESLHDPR/681 |
|
| Sterilisation: Definitive Cleaning of Reusable Medical Devices and Equipment
|
SESLHDPR/495 |
|
| Sterilisation: Designation of Reusable Medical Devices (RMDs) to a Product Family
|
SESLHDPR/627 |
|
| Subcutaneous Administration of 4% Glucose and 0.18% Sodium Chloride in the treatment of hypernatraemia and dehydration in selected aged care patients with advanced dementia
|
SESLHDGL/069 |
|
